A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic Adenocarcinoma

Amy Collins; Sylwia E. Wojcik; James Liu; Wendy L. Frankel; Hansjüerg Alder; Lianbo Yu; Thomas D Schmittgen; Carlo M. Croce; Mark Bloomston

doi:10.1245/s10434-013-3240-y

Related publications

Article2016

BA 4p BOLD response profile distinguishes low and high MS morbidity

Asaeyl Alahmadi, Matteo Pardini, Rebecca S. Samson, E D'Angelo, Karl Friston, Ahmed Toosy, Claudia A. M. Gandini Wheeler‐Kingshott

Article2023

Manic episode in a patient with pancreatic adenocarcinoma: a case report

J. I. Mena, Helena Andreu, Anna Giménez‐Palomo, Laura López, E. Cesari, Ó. De Juan, Iñaki Ochandiano, Luis Olivier, S. Salmerón, Eduard Vieta, Isabella Pacchiarotti

Article2009

Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma

Jong Kook Park, Eun Joo Lee, Christine Esau, Thomas D Schmittgen

Article2014

Occurrence of tertiary lymphoid tissue in pancreatic adenocarcinoma

Giuseppe Di, Giovanni Francesco Castino, Francesca Bergomas, Nina Cortese, Fabio Grizzi, Cristina Ridolfi, Francesca Gavazzi, Alberto Mantovani, Paola Allavena, Alessandro Zerbi, Federica Marchesi

Article2013

Occurrence of Tertiary Lymphoid Tissue in Pancreatic Adenocarcinoma

Giovanni Francesco Castino, Francesca Bergomas, Giuseppe Di, Fabio Grizzi, Cristina Ridolfi, Raffaella Gavazzi, Luigi Laghi, Alberto Mantovani, Alessandro Zerbi, Paola Allavena, Federica Marchesi